China Universal Asset Management Co., Ltd. Erasca, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Erasca, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 54,335 shares of ERAS stock, worth $138,554. This represents 0.02% of its overall portfolio holdings.
Number of Shares
54,335
Previous 30,527
77.99%
Holding current value
$138,554
Previous $72,000
105.56%
% of portfolio
0.02%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ERAS
# of Institutions
140Shares Held
229MCall Options Held
28.7KPut Options Held
117K-
Frazier Life Sciences Management, L.P. Menlo Park, CA19.4MShares$49.4 Million2.85% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.8MShares$42.9 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$41.4 Million4.58% of portfolio
-
Suvretta Capital Management, LLC New York, NY13.8MShares$35.1 Million1.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$33.9 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $311M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...